These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12070860)

  • 1. [Experiences with apomorphine SL in studies: tolerated therapy--even in problem patients].
    MMW Fortschr Med; 2002 May; Suppl 2():83. PubMed ID: 12070860
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerability and safety of apomorphine SL (Ixense (TM) ).
    Montorsi F
    Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
    Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
    Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of apomorphine SL (Uprima).
    Bukofzer S; Livesey N
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erectile dysfunction. Breaking through the silence].
    MMW Fortschr Med; 2002 May; Suppl 2():82-3. PubMed ID: 12070859
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction.
    Heaton JP; Dean J; Sleep DJ
    Int J Impot Res; 2002 Feb; 14(1):61-4. PubMed ID: 11896482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
    Heaton JP
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erectile dysfunction. Help also for cardiac patients].
    MMW Fortschr Med; 2001 Oct; 143(41):54. PubMed ID: 11721663
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating dose regimens of apomorphine, an open-label study.
    Kongkanand A; Opanuraks J; Tantiwongse K; Choeypunt N; Tantiwong A; Amornvejsukit T
    Int J Impot Res; 2003 Apr; 15 Suppl 2():S10-2. PubMed ID: 12825098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal apomorphine. Nastech Pharmaceutical.
    Kendirci M; Hellstrom WJ
    IDrugs; 2004 May; 7(5):483-8. PubMed ID: 15154111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug.
    Giuliano F; Allard J
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S53-6. PubMed ID: 11850736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future directions in erectile dysfunction therapy.
    Mulhall JP
    Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine SL (Uprima): a new treatment for the management of erectile dysfunction.
    Wagner G
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S1-2. PubMed ID: 11477485
    [No Abstract]   [Full Text] [Related]  

  • 14. Apomorphine to Uprima: the development of a practical erectogenic drug: a personal perspective.
    Morales A
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S29-34. PubMed ID: 11477489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Eardley I; Wright P; MacDonagh R; Hole J; Edwards A
    BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
    Perimenis P; Gyftopoulos K; Giannitsas K; Markou SA; Tsota I; Chrysanthopoulou A; Athanasopoulos A; Barbalias G
    Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of apomorphine SL in patients with erectile dysfunction.
    Buvat J; Montorsi F
    BJU Int; 2001 Oct; 88 Suppl 3():30-5. PubMed ID: 11578277
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apomorphine and erectile dysfunction].
    Tan DQ; Yao Y; Zhang J
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P; Fontana F; Zitella A; Montorsi F; Frea B
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.